Bill Rhodes

Bill Rhodes is an advisory board member at Nodexus. Bill was previously the chairman of the supervisory board at CytoSMART Technologies B.V. from May 2020 to March 2022, when the company was acquired by Axios Biosystems. Prior to that, they were with OpGen, Inc. and Altaris Capital Partners, LLC. Bill has also worked at Weill Cornell Medicine and Cornell University. Their most recent position was as managing partner at Third Day Advisors LLC.

Bill Rhodes received their BS in Entomology from Cornell University and their MS in International Business from Seton Hall University.